yahoo_financeOriginal article
CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight
Positive
AI Analysis
Summary
DelveInsight forecasts the CAR T-cell therapy market for Non-Hodgkin Lymphoma will grow at approximately 7% CAGR through 2036, driven by expanding indications and increased clinical adoption.
Importance:2/10
Sentiment:
0.50
CAR T-cell therapyNon-Hodgkin Lymphomamarket growthclinical adoption
Related Companies
Read the original article
Published by yahoo_finance on July 22, 2026 2:31 PM